Cellectar Biosciences, Inc.·4

Feb 24, 5:00 PM ET

Kolean Chad J 4

4 · Cellectar Biosciences, Inc. · Filed Feb 24, 2022

Insider Transaction Report

Form 4
Period: 2022-02-22
Kolean Chad J
VP, CFO and Treasurer
Transactions
  • Award

    Stock option (right to buy)

    2022-02-22+150,000150,000 total
    Exercise: $0.49Exp: 2032-02-22Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]This option shall vest in three equal annual installments beginning on the first anniversary of the date of grant.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4